Cell Counting Kit-8 (CCK-8)
目录号 : GK10001细胞计数试剂盒-8(CCK-8)是一种即用型的单瓶溶液,可快速、可靠地测量各种化学物质对细胞存活率和毒性的敏感度。
Sample solution is provided at 25 µL, 10mM.
- Adv Mater (2024):2401538.PMID:38738793
- Adv Mater (2023):2307193.PMID:37951210
- Adv Mater (2025):2413968.PMID:40223457
- Nat Microbiol (2025):1-16.PMID:39825096
- Cell Host Microbe 32.12 (2024):2195-2211.PMID:39610253
- Brain Behav Immun 110 (2023):60-79.PMID:36754245
- Adv Sci 7.9 (2020):1902938.PMID:32382476
- ACS nano 17.7 (2023):7017-7034.PMID:36971310
- Matter (2025).
- Nat Commun 15.1 (2024):72.PMID:38167723
- Nat Commun 14.1 (2023):3877.PMID:37391428
- Adv. Fiber Mater. (2025):1-17.
- Nat Commun 15.1 (2024):3771.PMID:38704377
- Autophagy 18.5 (2022):1049-1061.PMID:34517786
- Cancer Commun (2024).PMID:38512764
- Acs Nano (2024).PMID:39361472
- ACS nano (2025).PMID:39846120
- Cancer Commun 43.5 (2023):582-612.PMID:37005481
- Acta Pharm Sin B (2025).
- Brain Behav Immun (2024).PMID:38565398
- Nat Commun 16.1 (2025):3605.PMID:40240371
- Autophagy just-accepted (2024).PMID:39007910
- Adv Sci (2024):2401845.PMID:38757623
- Adv Sci 10.31 (2023):2301120.PMID:37688357
- Adv Sci (2023):2301107.PMID:37097746
- Adv-Sci 10.27 (2023):2302640.PMID:37485650
- Nat. Commun. 16.1 (2025):2551.
- Adv Sci (2024):2404365.PMID:39159143
- Sci Adv 10.10 (2024):eadg7380.PMID:38457499
- Adv Sci (2025):2417318.PMID:40472230
- Adv Sci (2024):2402450.PMID:38952061
- Adv Sci (2025):2417374.PMID:40213972
- Microbiome 12.1 (2024):152.PMID:39152482
- Adv Sci (2025):2413936.PMID:40047320
- Emerg Microbes Infec 12.1 (2023):2204164.PMID:37060263
- J Adv Res (2023).PMID:36933884
- Biomaterials (2025):123335.PMID:40222258
- Small (2024):2407674.PMID:39363789
- Water Res (2024):121379.PMID:38422694
- J Med Virol 95.10 (2023):e29171.PMID:37830751
- Small 21.3 (2025):2409121.PMID:39544127
- Nano Today 61 (2025):102560.
- J Exp Clin Canc Res 41.1 (2022):293.PMID:36199122
- J Hazard Mater (2024):135904.PMID:39303616
- Mol. Ther. 33.3 (2025):1134.PMID:39810420
- Mater Horiz (2024).PMID:39189308
- Gut Microbes 17.1 (2025):2446376.PMID:39718561
- Small Methods (2024):2400223.PMID:38602202
- Gut Microbes 16.1 (2024):2347757.PMID:38773738
- Mol Ther (2025).PMID:39810420
- Cell Death Differ 30.10 (2023):2293-2308.PMID:37608075
- Mater Horiz (2024).PMID:39189308
- Theranostics 14.16 (2024):6161.PMID:39431016
- Theranostics 12.7 (2022):3488.PMID:35547749
- J Control Release 373 (2024):749-765.PMID:39084465
- Cell Discov 6.1 (2020):96.PMID:33349633
- Redox Biol (2023):102983.PMID:38064762
- J Control Release 365 (2024):301-316.PMID:38007195
- J Exp Clin Canc Res 43.1 (2024):187.PMID:38965580
- Environ Sci Technol (2024).PMID:39364562
- Sci Total Environ 878 (2023):162942.PMID:36940749
- Environ Sci Technol 56.21 (2022):15096-15107.PMID:36099323
- J Exp Clin Canc Res 44.1 (2025):1-19.PMID:40069844
- J Adv Res (2025).PMID:40373960
- Cell Discov 6.1 (2020):96.PMID:33349633
- EBioMedicine 99 (2024).PMID:38101299
- J Adv Res (2025).
- J Exp Clin Canc Res 43.1 (2024):91.PMID:38528516
- J Exp Clin Canc Res 41.1 (2022):1-15.PMID:34980201
- J Immunother Cancer 12.3 (2024):e008054.PMID:38429070
- J Control Release 379 (2025):89-104.PMID:39756690
- J Exp Clin Canc Res 39 (2020):1-13.PMID:32028978
- J Control Release 360 (2023):647-659.PMID:37406817
- Water Res (2024):122403.PMID:39278116
- J Control Release 349 (2022):254-268.PMID:35803328
- Clin Transl Med 14.1 (2024):e1539.PMID:38224186
- Redox Biol 62 (2023):102663.PMID:36924682
- Acta Biomater 157 (2023):321-336.PMID:36481504
- J Exp Clin Canc Res 41 (2022):1-15.PMID:34980201
- J Control Release 359 (2023):12-25.PMID:37244298
- J Exp Clin Canc Res 41 (2022):1-15.PMID:34980201
- View-China (2025):20240103.
- J Nanobiotechnol 22.1 (2024):1-21.PMID:38448959
- Cardiovasc Res 121.2 (2025):324-338.PMID:39658102
- ENGINEERING-PRC (2025).
- Acta Biomater (2024).PMID:38452962
- Adv Healthc Mater (2025):2500845.PMID:40400499
- J Nanobiotechnol 20.1 (2022):1-20.PMID:36123708
- Adv Healthc Mater 11.8 (2022):2102395.PMID:34874119
- Sci Total Environ 897 (2023):165514.PMID:37451464
- Environ Health Persp 131.6 (2023):067004.PMID:37267060
- Cancer Lett (2024):216765.PMID:38408604
- Rare Met. (2025):1-23.
- Pharmacol Res 187 (2023):106563.PMID:36410674
- J Nanobiotechnol 21.1 (2023):354.PMID:37775761
- Adv Healthc Mater 13.8 (2024):2303215.PMID:38112062
- J Immunother Cancer 12.10 (2024):e009416.PMID:39455095
- J Nanobiotechnol 22.1 (2024):1-15.PMID:38790037
- Adv Healthc Mater (2024):2402877.PMID:39434433
- Adv Healthc Mater (2024):2401061.PMID:38849128
- J Nanobiotechnol 23.1 (2025):1-22.PMID:39871272
- J Nanobiotechnol 20.1 (2022):1-20.PMID:36123708
- J Neuroinflamm 20.1 (2023):1-16.PMID:36944954
- Adv Healthc Mater 12.9 (2023):2202785.PMID:36541060
- J Immunother Cancer 13.6 (2025):e011717.PMID:40473272
- Environ Pollut 334 (2023):122148.PMID:37419204
- Liver Int 43.4 (2023):840-854.PMID:36737842
- CANCER LETT (2025):217685.
- Pharmacol Res 195 (2023):106877.PMID:37524154
- Mater. Today Bio (2025):101703.
- Cell Mol Life Sci 80.3 (2023):61.PMID:36763212
- Biomark Res 11.1 (2023):3PMID:36611218
- Environ Pollut 338 (2023):122581.PMID:37748638
- Acs Appl Mater Inter 15.32 (2023):38294-38308.PMID:37542453
- Mol Ther-Nucl Acids 31 (2023):703-716.PMID:36923951
- Pharmacol Res 180 (2022):106225.PMID:35452801
- Cell Mol Life Sci 79.7 (2022):382.PMID:35751755
- ACS Appl Mater Inter 14.13 (2022).PMID:35344348
- Cell Death Dis 13.10 (2022):858.PMID:36209201
- Acs Appl Mater Inter (2024).PMID:38345297
- J Colloid Interf Sci (2025):137652.
- Food Chem (2024):139505.PMID:38703732
- Acta Biomater 113 (2020):393-406.PMID:32629189
- Cell Death Dis 13.5 (2022):497.PMID:35614040
- Acta Biomater (2025).PMID:40024424
- Front Immunol 14 (2023):1130308.PMID:37006248
- J Colloid Interf Sci (2025):.PMID:39755016
- Brit J Cancer (2024):1-9.PMID:38594370
- Acs Appl Mater Inter 15.11 (2023).PMID:36897565
- Cancer Lett 611 (2025):217418.PMID:39725146
- Cell Mol Biol Lett 29.1 (2024):103.PMID:38997648
- Cancer Lett (2024):217418.PMID:39725146
- Pharmacol Res (2024):107460.PMID:39393436
- Acta Biomater (2025).PMID:39952883
- Environ Res (2024):118221.PMID:38246300
- Int J of Bio Macromol (2024):132103.PMID:38719011
- Cell Commun Signal 22.1 (2024):293.PMID:38802896
- Cell Death Dis 12.4 (2021):408.PMID:33859186
- Int Immunopharmacol 158 (2025):114885.PMID:40383096
- Cell Mol Life Sci 81.1 (2024):32.PMID:38214780
- INT J BIOL SCI 21.7 (2025):3099-3121.
- Cell Death Dis 13.3 (2022):233.PMID:35288538
- Cell Commun Signal 22.1 (2024):1-19.PMID:38454413
- Cell Death Dis 12.8 (2021):779.PMID:34365463
- Mater Today Bio (2024):101019.PMID:38516170
- Int J Biol Macromol (2024):131928.PMID:38688339
- Acs Sensors (2024).PMID:38958530
- Cell Mol Biol Lett 29.1 (2024):83.PMID:38822277
- CANCER IMMUNOL RES (2025).PMID:40323348
- Front Immunol 16 (2025):1569210.PMID:40396173
- Phytomedicine 122 (2024):155091.PMID:37844378
- Int J Biol Macromol 220 (2022):371-384.PMID:35970372
- Free Radical Bio Med 190 (2022):202-215.PMID:35985562
- Phytomedicine 122 (2024):155091.PMID:37844378
- Acs Omega (2025).
- Int J Biol Macromol (2024):133667.PMID:38969038
- Mater Today Bio (2025):101901.
- Int. J. Biol. Macromol. (2025):143759.
- Biomater Sci-UK 10.17 (2022):5006-5017.PMID:35815806
- Sci Rep-Uk 15.1 (2025):1-16.PMID:40436970
- Int J Biol Macromol 224 (2023):797-809.PMID:36283555
- Free Radical Bio Med 188 (2022):404-418.PMID:35787451
- Phytomedicine (2023):155270.PMID:38096717
- Sci Rep-Uk 15.1 (2025):1-17.PMID:40383858
- Int. J. Biol. Markers (2025):143683.PMID:40318724
- Int J Biol Macromol (2024):129172.PMID:38176496
- Sci Rep-Uk 15.1 (2025):1-14.PMID:40450025
- Cell Mol Life Sci 81.1 (2024):143.PMID:38493426
- Int J Biol Macromol 306 (2025):141410.PMID:40010477
- Sci China Life Sci (2025):1-11.PMID:39821161
- Cell Death Dis 15.11 (2024):826.PMID:39543094
- Acs Appl Mater Inter (2025).PMID:39853325
- Cell Death Dis 16.1 (2025):240.PMID:40175350
- Acs Appl Mater Inter (2024).PMID:39320506
- Int J Biol Macromol (2024):135979.PMID:39332550
- Antivir Res 205 (2022):105381.PMID:35835291
- Int J Biol Macromol (2025):141146.PMID:39986528
- Int. J. Biol. Macromol. (2025):142238.PMID:40112979
- Int J Biol Macromol(2023):125130.PMID:37263336
- Int J Biol Macromol (2025):140602.PMID:39922352
- Nanoscale Horiz (2025).
- Acs Appl Mater Inter (2024).PMID:39448903
- Int J Biol Macromol (2025):140374.PMID:39880265
- Int J Biol Macromol (2025):140632.PMID:39909240
- Int J Biol Sci 21.4 (2025):1837-1851.
- Int J Biol Macromol (2024):136818.PMID:39447809
- Int J Biol Macromol (2025):141767.
- Acs Appl Mater Inter (2025).PMID:40025657
- Int J Biol Macromol (2024):137561.PMID:39537068
- Oncogene (2023):1-13.PMID:37138031
- Phytomedicine 118 (2023):154944.PMID:37393830
- Int J Biol Macromol (2024):135562.PMID:39276884
- Cell Commun Signal 22.1 (2024):1-23.PMID:39696352
- Int J Biol Sci 21.2 (2025):614.PMID:39781455
- Int J Biol Macromol 222 (2022):1789-1800.PMID:36191790
- Biomed Pharmacother 129 (2020):110315.PMID:32554246
- Int J Biol Macromol 211 (2022):128-139.PMID:35561854
- Int J Biol Macromol 211 (2022):128-139.PMID:35561854
- Phytomedicine 130 (2024):155744.PMID:38763011
- Biomed Pharmacother 130 (2020):110566.PMID:32755793
- Fertil Steril (2023).PMID:37178109
- Front Cell Dev Biol 9 (2021):696558.PMID:34447749
- Ecotox Environ Safe 270 (2024):115813.PMID:38113798
- Front Immunol 13 (2022):902515.PMID:35874682
- Front Immunol 13 (2022):986214.PMID:36341437
- Food Res Int (2025):115940.
- Biomed Pharmacother 177 (2024):117037.PMID:38959602
- Ecotox Environ Safe 280 (2024):116579.PMID:38865940
- Int J Nanomed (2024):13183-13199.PMID:39664759
- Front Cell Dev Biol 9 (2021):749210.PMID:34676217
- Phytomedicine (2025):156928.
- Phytomedicine (2025):156515.PMID:39983438
- Front Cell Dev Biol 10 (2022):850708.PMID:35592246
- Acta Pharmacol Sin (2025):1-15.PMID:39984622
- Front Immunol 14 (2023):1111494.PMID:36817451
- Biomed Pharmacother 184 (2025):117907.PMID:39978030
- Ecotox Environ Safe 262 (2023):115161.PMID:37356398
- Biomed Pharmacother 174 (2024):116470.PMID:38565061
- Cell Death Discov 10.1 (2024):7.PMID:38182573
- Oncogenesis 11.1 (2022):21.PMID:35487890
- Bioeng Transl Med 8.3 (2023):e10475.PMID:37206234
- J Med Virol 96.11 (2024):e70049.PMID:39558699
- J Med Chem (2024).PMID:38315032
- Oncogene (2025):1-15.PMID:39920289
- J Mater Chem B 11.16 (2023):3740-3751.PMID:37067505
- Int J Nanomed 20 (2025):293-308.
- Cell Death Discov 10.1 (2024):97.PMID:38402198
- J Med Chem 65.4 (2021):2794-2808.PMID:33872498
- Brit J Pharmacol (2024).PMID:38715438
- Cell Biol Toxicol 38.6 (2022):1121-1136.PMID:35348966
- Phytother Res (2024).PMID:38558449
- Free Radical Bio Med (2024).PMID:38367927
- Eur J Med Chem 238 (2022):114458.PMID:35635946
- Stem Cell Res Ther 15.1 (2024) 385.PMID:39468662
- Plos Pathog 17.3 (2021):e1009393.PMID:33684175
- Front Nutr 9 (2022):812623.PMID:35419394
- Clin Epigenetics 14.1 (2022):1-12.PMID:35414117
- Biomed Pharmacother 122 (2020):109690.PMID:31786468
- Antioxid Redox Sign 37.13 (2022):867-886.PMID:35350885
- J Med Chem (2025).PMID:39842821
- Virol Sin (2023).PMID:37331658
- Mater Today Bio 15 (2022):100264.PMID:35517578
- Biomed Pharmacother 158 (2023):114118.PMID:36527845
- J Gastroenterol (2023):1-14.PMID:37150773
- Cell Rep 44.3 (2025).PMID:39977268
- J Med Chem (2024).PMID:39292661
- Stem Cell Res Ther 16.1 (2025):119.PMID:40050973
- Wirel Commun Mob Com 2 (2022):3.PMID:36120596
- Ecotox Environ Safe 266 (2023):115571.PMID:37837696
- J Polym Environ (2025):1-16.
- Biomed Pharmacother 162 (2023):114602.PMID:37018993
- Cell Death Discov 11.1 (2025):1-16.PMID:40399275
- AGING DIS 17.1 (2026):2.PMID:40072367
- J. Environ. Chem. Eng. (2025):116286.
- Food Chem Toxicol 148 (2021):111972.PMID:33421461
- Stem Cell Res Ther 16.1 (2025):1-18.PMID:40361250
- Iscience (2025).
- Life Sci 308 (2022):120925.PMID:36057399
- Life Sci 312 (2023):121092.PMID:36279968
- Stem Cell Res Ther 15.1 (2024):1-18.PMID:39267160
- Embo Rep (2025):1-23. PMID:40185977
- Anal Chem 95.31 (2023):11664-11671.PMID:37495553
- Front Immunol 14 (2023).PMID:37662906
- J Cell Physiol 238.1 (2023):195-209.PMID:36436184
- Int J Nanomed (2025):4535-4550.PMID:4023652
- Phytother Res 37.10 (2023):4639-4654.PMID:37394882
- Npj Precis Oncol 9.1 (2025):112.PMID:40240582
- Biomed Pharmacother 165 (2023):115261.PMID:37549461
- Biomed Pharmacother 179 (2024):117415.PMID:39265236
- Biomed Pharmacother 188 (2025):118217.PMID:40435839
- Bba-Mol Basis Dis 1869.1 (2023):166571.PMID:36244542
- Stem Cell Res Ther 10.1 (2019):1-14.PMID:31847890
- Plos Pathog 19.10 (2023):e1011702.PMID:37801439
- Bba Mol Basis Dis 1869.7 (2023):166725.PMID:37127173
- Inflamm Res 74.1 (2025):1-22.PMID:40439750
- Chem-Biol Interact (2025):111576.PMID:40456372
- Cell Death Discov 11.1 (2025):1-12.PMID:40456746
- Cell Death Discov 9.1 (2023):415.PMID:37968255
- Biomed Pharmacother 168 (2023):115751.PMID:37879214
- Phytomedicine (2024):155859.PMID:38972239
- J Med Virol 97.3 (2025):e70267.
- Phytomedicine (2025):156860.
- Nanoscale 16.17 (2024):8479-8494.PMID:38590261
- Phytomedicine (2025):156598.
- Front Oncol 12 (2022):770628.PMID:35372056
- Apoptosis 28.3-4 (2023):414-431.PMID:36482019
- Front Pharmacol 13 (2022):946193.PMID:36091823
- Cells 11.24 (2022):4094.PMID:36552856
- Front Oncol 13 (2023):1132424.PMID:37251940
- Cells 11.23 (2022):3816.PMID:36497076
- Int J Biochem Cell B 153 (2022):106317.PMID:36283586
- Cancer Cell Int 23.1 (2023):142.PMID:37468908
- Cns Neurosci Ther (2023).PMID:37452510
- J Agr Food Chem 70.50 (2022):15763-15775.PMID:36472370
- Acs Biomater Sci Eng (2024).PMID:38445959
- Front Cell Dev Biol 10 (2022):787730.PMID:35445026
- Front Pharmacol 14 (2023):1168393.PMID:37124212
- Chinese Med J-Peking 136.05 (2023):556-564.PMID:36939243
- J Enzym Inhib Med Ch 39.1 (2024):2288810.PMID:38059334
- Int-Immunopharmacol 124 (2023):110809.PMID:37690240
- Exp Neurol 359 (2023):114266.PMID:36336032
- Aging (Albany NY) 13.17 (2021):21712.PMID:34518442
- Colloid Surface B 222 (2023):113119.PMID:36621177
- Int J Mol Sci 22.21 (2021):11893.PMID:34769322
- Am J Cancer Res 13.5 (2023):2135.PMID:37293170
- Acs Biomater Sci Eng (2024).PMID:38446137
- Front Pharmacol 13 (2022):819826.PMID:35645824
- Front Pharmacol 13 (2022):965131.PMID:36249790
- Mol Neurobiol 59.12 (2022):7075-7094.PMID:36083519
- Front Pharmacol 13 (2022):972397.PMID:36188529
- Front Cell Dev Biol 9 (2022):793793.PMID:35155447
- Am J Chinese Med (2024):1-23.PMID:38490807
- Life Sci (2024):122483.PMID:38307238
- Cancer Gene Ther 29.8-9 (2022):1228-1239.PMID:35115683
- Eur J Pharm Biopharm 188 (2023):89-99.PMID:36702198
- Mol Med 30.1 (2024):14.PMID:38254010
- Faseb J 37.5 (2023):e22935.PMID:37086094
- Aging (Albany NY) 15.12 (2023):5673.PMID:37387540
- Front Pharmacol 13 (2022):1043022.PMID:36588728
- Front Pharmacol 13 (2022):927488.PMID:35935870
- J Agr Food Chem 71.1 (2022):546-556.PMID:36538589
- Chinese Med J-Peking (2023):10-1097.PMID:36939243
- Biomolecules 12.9 (2022):1283.PMID:36139122
- Biochem Pharmacol (2023):115632.PMID:37263300
- Int J Mol Sci 24.22 (2023):16503.PMID:38003694
- Front Cell Dev Biol (2023):1161541.PMID:37325570
- Int J Mol Sci 23.22 (2022):14306.PMID:36430782
- Mbio (2023):e01688-23.PMID:37882780
- Int J Biochem Cell B 153 (2022):106317.PMID:36283586
- Resp Res 24.1 (2023):216.PMID:37674165
- Phytother Res (2023).PMID:37246830
- Biochem Pharmacol 213 (2023):115592.PMID:37196680
- Int Immunopharmacol 113 (2022):109342.PMID:36327871
- Int J Mol Sci 23.24(2022):16045.PMID:36555684
- J Agr Food Chem 71.3 (2023):1593-1606.PMID:36634077
- Mar Life Sci Tech 4.3 (2022):373-383.PMID:37073164
- Biochem Pharmacol (2024):116044.PMID:38336157
- Front Oncol 13 (2023):1120103.PMID:36959804
- Front Oncol 12 (2022):858598.PMID:35321435
- Lab Invest 102.4 (2022):411-421.PMID:34775495
- Phytother Res (2023).PMID:37086359
- J Agr Food Chem (2023).PMID:37922022
- Ecotox Environ Safe 233 (2022):113315.PMID:35189521
- Int J Pharmaceut (2023):123142.PMID:37328119
- Int Immunopharmacol 121 (2023):110413.PMID:37301119
- Front Pharmacol 13 (2022):1015693.PMID:36210855
- Cell Death Discov 11.1 (2025):74.PMID:39988672
- Microbiol Res (2024):127927.PMID:39393129
- Neurotoxicol Teratol (2025):107500.PMID:40456500
- J Agr Food Chem (2025).PMID:39962827
- Lab Chip (2024).PMID:38939907
- Jci Insight (2024). PMID:38935435
- Mol Cell Proteomics (2025):100930.PMID:40024376
- J Agr Food Chem (2025).PMID:40017402
- Biomater Adv (2024):214069.PMID:39447240
- Biomater Adv (2025):214257.PMID:40023084
- Front Immunol 15 (2024):1375781.PMID:39391314
- Antioxid Redox Sign (2025).PMID:40455659
- Front Immunol 15 (2024):1455996.PMID:39376562
- Molecular Therapy Oncology 32.2 (2024).PMID:38948919
- Cell Mol Life Sci 81.1 (2024):265.PMID:38880863
- J Transl Med 23.1 (2025):131.PMID:39885513
- Cancer Cell Int 20 (2020):1-14.PMID:33292221
- J Invest Dermatol (2025).PMID:39892773
- J Nutr Biochem (2024):109678.PMID:38844080
- Mol Neurobiol 58 (2021):1990-2004.PMID:33411316
- Aging (Albany NY) 13.3 (2021):4482.PMID:33495411
- Int J Mol Med 54.6 (2024):1-17.PMID:39364745
- Front Immunol 15 (2024):1455996.PMID:39376562
- Talanta (2025):127591.PMID:39847915
- J Transl Med 22.1 (2024):1-17.PMID:39267037
- BREAST CANCER RES 27.1 (2025):61.PMID:40270028
- Aging (Albany NY) 16.11 (2024):9625.PMID:38829771
- Apoptosis (2025):1-17.PMID:40347321
- Jci insight 9.15 (2024):PMID:38935435
- Front Immunol 16 (2025):1569210.
- J Invest Dermatol (2025).PMID:39892773
- J Transl Med 22.1 (2024):1-19.PMID:39107788
- Microbiol Res (2025):128183.
- J Transl Med 22.1 (2024):1-15.PMID:39256832
- Phytother. Res. 39.3 (2025):1355-1371.PMID:39764683
- Front Immunol 15 (2024):1375781.PMID:39391314
- Apoptosis (2024):1-19.PMID:39097858
- MOL MED 31.1 (2025):126.PMID:40186145
- Mol Med 30.1 (2024):1-18.PMID:39266965
- Mol Med 31.1 (2025):1-15.PMID:40369420
- Front Immunol 16 (2025):1521965.PMID:40191190
- Biomacromolecules (2025).
- J Agr Food Chem (2025).PMID:40152883
- Front. Immunol. 16 (2025):1556715.
- Front Pharmacol 11 (2020):16.PMID:32140106
- Mol Med 31.1 (2025):1-15.PMID:40405066
- Front Pharmacol 12 (2021):610158.PMID:33762939
- J Mater Chem B (2024).PMID:39119756
- Cancer Gene Ther (2021)1-12.PMID:33888871
- Int J Mol Med 55.3 (2025):45.PMID:39791203
- Ecotox Environ Safe 287 (2024):117331.PMID:39547060
- Int J Mol Med 55.3 (2025):1-14.PMID:39791203
- Cancer Cell Int 21 (2021):1-12.PMID:34281530
- Ecotox Environ Safe 289 (2025):117511.PMID:39662457
- Front Pharmacol 12 (2021):649398.PMID:34335241
- Front Pharmacol 12 (2021):673263.PMID:34108880
- Int J Mol Med 55.4 (2025):1-16.PMID:39918010
- Front Immunol 15 (2024):1455996.PMID:39376562
- Int Immunopharmacol 132 (2024):111870.PMID:38547771
- Int J Mol Med 55.3 (2025):1-17.
- Front Bioeng Biotech 12 (2024):1361682.PMID:38562665
- Bba-Mol Basis Dis (2024):167210.PMID:38704001
- Am J Physiol-Cell Ph (2024).PMID:38525543
- Mol Med 30 (2024):260.PMID:39707194
- Liver Int 45.2 (2025):e16246.PMID:39821525
- Int Immunopharmacol 131 (2024):111922.PMID:38522137
- Stem Cell Transl Med (2024):szae020.PMID:38530131
- Front Oncol 12 (2022):858598.PMID:35321435
- Cancer Cell Int 24.1 (2024):123.PMID:38566075
- Biochem Pharmacol (2024):116688.PMID:39617210
- CANCER CELL INT 25.1 (2025):1-24.PMID:40296031
- Glia (2024).PMID:39610064
- Redox Rep 29.1 (2024):2398380.PMID:39284588
- J. Drug Delivery Sci. Technol. (2025):106841.
- Drug Deliv Transl Re (2023):1-13.PMID:37130996
- Bone Joint Res 13.12 (2024):763.PMID:39662502
- Invest Ophth Vis Sci 66.1 (2025):24-24.PMID:39792075
- J Ethnopharmacol (2024):119272.PMID:39716512
- Int Immunopharmacol 147 (2025):113871.PMID:39798467
- Transl Oncol 56 (2025):102396.PMID:40239242
- J. Ethnopharmacol. (2025):119727.PMID:40187623
- Transl Oncol 52 (2025):102256.PMID:39733744
- J Ethnopharmacol 307 (2023):116193.PMID:36746295
- Sci Rep-Uk 13.1 (2023):361.PMID:36611103
- Front Endocrinol 13 (2022):657802.PMID:36263320
- Chem-Biol Interact 382 (2023):110638.PMID:37473910
- Mol. Nutr. Food Res. (2025):e70053.PMID:40177855
- Front Oncol 12 (2022):1043161.PMID:36439418
- ACS Appl. Nano Mater. (2025).
- Front Oncol 12 (2022):961653.PMID:36457504
- Radiother Oncol (2024):110686.PMID:39709027
- Exp Neurol (2025):115252.PMID:40221008
- Food Biosci (2025):106564.
- Toxicology (2024):154018.PMID:39608440
- Molecules 27.21 (2022):7183.PMID:36364008
- Molecules 28.6 (2023):2426.PMID:36985397
- Drug Des Dev Ther (2025):281-302.PMID:39845152
- Life Sci (2024):123148.PMID:39447733
- J Neurochem 164.5 (2023):643-657.PMID:36527420
- Int Immunopharmacol 141 (2024):112955.PMID:39163685
- Pharmaceuticals 15.11 (2022):1435.PMID:36422564
- Pharmaceuticals 15.10 (2022):1271.PMID:36297383
- Microorganisms 11.5 (2023):1268.PMID:37317242
- J Agr Food Res (2025):101694.
- Int Immunopharmacol 138 (2024):112533.PMID:38924868
- Commun Biol 8.1 (2025):71.PMID:39820362
- J Drug Deliv Sci Tec 104 (2025) 106577.
- J-Ethnopharmacol (2023):116729.PMID:37277081
- Molecules 27.23 (2022):8568.PMID:36500666
- Bone Joint Res 13.12 (2024):763-777.PMID:39662502
- Molecules 27.17 (2022):5698.PMID:36080465
- J Hepatocell Carcino (2023):863-881.PMID:37313303
- Molecules 27.14 (2022):4603.PMID:35889477
- Front Endocrinol 13 (2022):998971.PMID:36147560
- Front Oncol 12 (2022):996080.PMID:36483054
- J Dent (2024):105436.PMID:39488296
- J Nutr Biochem (2024):109780.PMID:39395694
- Radiother Oncol 203 (2025):110686.PMID:39709027
- Nutrients 17.5 (2025):923.PMID:40077793
- Mol Neurobiol 59.8 (2022):4776-4790.PMID:35622272
- Bioorg Chem 136 (2023):106556.PMID:37105002
- J Oncol 2022 (2022):6459029PMID:36199788
- J Ethnopharmacol (2024):119073.PMID:39522846
- Colloid Surface B (2025):114537.PMID:39879672
- J Oncol 2022 (2022).PMID:36281290
- J Ethnopharmacol 310 (2023):116375.PMID:36934787
- Acs Infect Dis 8.9 (2022):1851-1868.PMID:35948057
- J Oncol 2022 (2022).PMID:36213838
- J Dent (2024):105436.PMID:39488296
- Bioengineering 9.9 (2022):433.PMID:36134979
- J Virol (2023):e00549-23.PMID:37222617
- J Dermatol Sci 109.2 (2023):52-60.PMID:36858850
- J Ethnopharmacol (2023):116731.PMID:37277084
- Front Cell Dev Biol 12 (2024):1391873.PMID:39170916
- Eur-J Pharmacol 958 (2023):176033.PMID:37673365
- J Ethnopharmacol (2024):117865.PMID:38369066
- Int Immunopharmacol 138 (2024):112533.PMID:38924868
- Environ Toxicol (2023).PMID:38069587
- J Cell Mol Med 26.13 (2022):3783-3796.PMID:35656815
- Invest Ophth Vis Sci 63.6 (2022):13-13.PMID:35695808
- Int Immunopharmacol 138 (2024):112539.PMID:38936054
- Int Immunopharmacol 138 (2024):112559.PMID:38955028
- Macromol Biosci (2024):2400003.PMID:38597147
- Life Sci 254 (2020):117793.PMID:32416164
- Transl Oncol 47 (2024):102042.PMID:38924847
- Arch Toxicol (2024):1-16.PMID:38971901
- Cell Signal (2023):110987.PMID:38029946
- Cell Cycle 21.8 (2022):835-850.PMID:35100080
- Am J Cancer Res 14.1 (2024):324.PMID:38323285
- Bioorg Chem (2025):108656.
- J Virol 97.11 (2023):e00719-23.PMID:37929962
- Aging (Albany NY) 15.23 (2023):14292.PMID:38059876
- Int. J. Mol. Sci. 26.9 (2025):4325.
- Cell Signal 113 (2024):110962.PMID:37931691
- Int Immunopharmacol 107 (2022):108695.PMID:35305385
- Am J Physiol-Gastr L (2024).PMID:38742280
- Antimicrob Agents Ch 65.6 (2021):10-1128.PMID:33753340
- Int Immunopharmacol 108 (2022):108742.PMID:35378447
- Aging 16.8 (2024):6773-6795.PMID:38643468
- Environ Toxico (2024).PMID:38700384
- Biotechnol J 19.1 (2024):2300453.PMID:37899497
- Diabetol Metab Syndr 16.1 (2024):1-14.PMID:38317244
- Cell Cycle 19.17 (2020):2139-2147.PMID:32779548
- Acs Appl Bio Mater (2024).PMID:38700956
- Cell Death Discov 8.1 (2022):85.PMID:35220396
- Macromol Biosci (2024):2400003.PMID:38597147
- J Ethnopharmacol 319 (2024):117205.PMID:37741473
- Aging (Albany NY) 16.8 (2024):6773.PMID:38643468
- Mol Nutr Food Res (2024):2300912.PMID:38847553
- J Ethnopharmacol 319 (2024):117091.PMID:37634753
- Arch Toxicol (2025):1-17.PMID:40464975
- Bioorg Chem (2025):108667.
- Antivir Ther 30.3 (2025):13596535251345953.PMID:40434182
- Sci Rep-Uk 13.1 (2023):14339.PMID:37658227
- J Ethnopharmacol (2024):118080.PMID:38521426
- J Cell Mol Med 28.6 (2024):e18223.PMID:38451046
- J oncol 2022 (2022).PMID:36385962
- Acs Biomater Sci Eng (2024).PMID:39164198
- J Ethnopharmacol (2024):118685.PMID:39127116
- Cell Cycle 21.3 (2022):228-246.PMID:34965191
- Burns Trauma 12 (2024):tkae001.PMID:38434722
- Mol Carcinogen (2023).PMID:37750597
- Mol Carcinogen 62.2 (2023):160-173.PMID:36222184
- J Ethnopharmacol (2024):117985.PMID:38417600
- J Oncol 2022 (2022).PMID:36213831
- Food Funct. (2025).
- Biochem Pharmacol (2024):116438.PMID:39025409
- Am J Physiol-Cell Ph (2024).PMID:39069827
- J Cell Mol Med 24.7 (2020):4136-4149.PMID:32100443
- Antimicrob Agents Ch 65.6 (2021):10-1128.PMID:33753340
- J Ethnopharmacol (2024):117958.PMID:38395179
- Mol Neurobiol (2025):1-16.PMID:40402409
- Int J Mol Sci 26.10 (2025):4953.PMID:40430095
- Int Immunopharmacol 159 (2025):114886.PMID:40424656
- Clin Immunol (2024):110308.PMID:39002794
- Faseb J 38.7 (2024):e23591.PMID:38572579
- Cns Neurosci Ther 31.5 (2025):e70437.PMID:40400263
- Int Immunopharmacol 138 (2024):112625.PMID:38996666
- Int J Mol Med 52.5 (2023):1-14.PMID:37800609
- Mol Neurobiol (2024):1-18.PMID:38995443
- Heliyon (2024).PMID:38707472
- J Biochem Mol Toxic 38.4 (2024):e23675.PMID:38488158
- Gene (2024):148399.PMID:38518902
- Bmc Genomics 25.1 (2024):1-13.PMID:38395755
- Sci Rep-Uk 14.1 (2024):25636.PMID:39465338
- J Inflamm Res (2024):10533-10546.PMID:39659750
- Acta Derm-Venereol 104 (2024).PMID:38590175
- Microbiol Spectr (2024):e04142-23.PMID:38421191
- J Pharmacol Exp Ther 388.3 (2024):827-845.PMID:38262745
- Endocrine (2024):1-14.PMID:38378893
- J Cancer 15.5 (2024):1397.PMID:38356722
- Bmc Cancer 24.1 (2024):465.PMID:38622522
- Front Pharmacol 15 (2024):1453938.PMID:39654626
- Toxicol Sci (2024):kfae054.PMID:38636494
- Bmc Complement Med 24.1 (2024):1-16.PMID:38580999
- Sci Rep-Uk 14.1 (2024):27063.PMID:39511266
- J Neuro Oncol (2023):1-16.PMID:37351767
- Heliyon 8.11 (2022).PMID:36353164
- J Inflamm Res (2024):8009-8026.PMID:39507268
- Brain Res Bull (2024):111165.PMID:39667505
- Front Oncol 14 (2024):1471109.PMID:39582546
- J Inflamm Res (2024):8009-8026.PMID:39507268
- J Biochem Mol Toxic 38.1 (2024):e23544.PMID:37815058
- Rsc Adv 14.18 (2024):12864-12872.PMID:38650686
- Front Oncol 14 (2024):1440906.PMID:39346724
- Pediatr Res (2024):1-10.PMID:38658662
- Rsc Adv 13.32 (2023):22367-22374.PMID:37497090
- Bba-Mol Basis Dis (2024):167354.PMID:39004378
- Biomed Mater 18.6 (2023):065026.PMID:37852221
- Sci Rep-Uk 14.1 (2024):21680.PMID:39289451
- Eur J Pharm Biopharm (2024):114417.PMID:39013493
- Eur J Pharmacol (2024):176995.PMID:39277096
- Front Pharmacol 15 (2024):1397761.PMID:39104391
- Front Pharmacol 15 (2024):1424624.PMID:25956975
- Langmuir 39.39 (2023):14162-14172.PMID:37722015
- Metabolomics 20.5 (2024):112.PMID:39369160
- Rsc Adv 13.33 (2023):23010-23020.PMID:37529353
- Mol Cell Biochem (2024):1-15.PMID:39179754
- Sci Rep-Uk 14.1 (2024):19292.PMID:39164313
- Aging (Albany NY) 16.14 (2024):11339.PMID:39029955
- Bba-Mol Basis Dis (2024):167467.PMID:39159699
- Sci Rep-Uk 14.1 (2024):18929.PMID:39147857
- Bmc Cancer 24.1 (2024):1-16.PMID:38475728
- Epigenetics-Us 18.1 (2023):2254976.PMID:37691391
- Mol Cells 46.4 (2023):231-244.PMID:36625319
- J Steroid Biochem (2023):106429.PMID:38035949
- Cytokine 176 (2024):156507.PMID:38244240
- Oral Dis (2024).PMID:38168877
- Endocrine (2024).PMID:38191984
- Bmc Complement Med 24 (2024).PMID:38783288
- J Gen Virol 105.1 (2024):001944.PMID:38180473
- Gerontology (2024).PMID:38168028
- Toxicol Lett 379 (2023):20-34.PMID:36905973
- J Cell Mol Med 28.20 (2024):e70163.PMID:39462268
- Cancer Biol Ther 25.1 (2024):2355705.PMID:38778753
- J Immunother (2024):10-1097.PMID:38847148
- Bmc Chem 18.1 (2024):1-11.PMID:39396055
- Zool Res 45.5 (2024):1001.PMID:39147715
- Sci Rep-Uk 14.1 (2024):14438.PMID:38910141
- Toxicol Appl Pharm (2023):116794.PMID:38142782
- Eur J Pharmacol 983 (2024):176995.PMID:39277096
- Gene (2023):148050.PMID:38042211
- Zool Res 45.5 (2024).PMID:39147715
- Environ Toxicol (2024).PMID:39400944
- J Biol Chem (2024):107499.PMID:38944125
- Cancer Biol Ther 25.1 (2024):2325126.PMID:38445610
- Toxicol Appl Pharm 410 (2021):115361.PMID:33285147
- Bmc Cancer 22.1 (2022):1-14.PMID:35387643
- Food Chem. Toxicol. (2025):115488.PMID:40288513
- Am J Transl Res 13.10 (2021):11255.PMID:34786056
- Metab Brain Dis 38.1 (2023):255-267.PMID:36445630
- Front Pharmacol 15 (2025):1534772.PMID:39911826
- Faseb J 39.2 (2025):e70314.PMID:39825721
- Bmc Cancer 21.1 (2021):1181.PMID:34740322
- Mol Immunol 153 (2023):126-134.PMID:36495817
- Bmc Med Genomics 15.1 (2022):1-19.PMID:36503492
- Eur J Pharmacol (2025):177343.PMID:39900330
- Front. Oncol. 15 (2025):1536473.PMID:40303992
- Sci Rep-Uk 15.1 (2025):13282.PMID:40247060
- Oncol Rep 46.6 (2021):1-12.PMID:34643248
- Metab Brain Dis 37.7 (2022):2349-2362.PMID:35779150
- Transl Oncol 14.12 (2021):101219.PMID:34555726
- J. Funct. Foods 128 (2025):106822.PMID:39486993
- Arthritis Res Ther 27.1 (2025):12.PMID:39838477
- Front Toxicol 7 (2025):1598185.PMID:40376450
- Probiotics Antimicro (2025):1-16.PMID:40366615
- Bmc Cancer 21.1 (2021):1-15.PMID:34130645
- Molecules 30.3 (2025):549.PMID:39942654
- Inflammation 45.1 (2022):372-386.PMID:34792688
- Hypertens Res 45.4 (2022):650-664.PMID:35082376
- Sci. Rep. 15.1 (2025):15556.PMID:40319036
- Front Pharmacol 16 (2025):1536091.PMID:40041493
- J. Biomed. Mater. Res. Part A 113.3 (2025):e37893.PMID:40059713
- Front. Pharmacol. 16 (2025):1545498.
- Eur J Pharmacol (2025):177497.PMID:40058753
- Mol Cell Biochem (2025):1-20.PMID:40032749
- Hum Cell 35.4 (2022):1140-1158.PMID:35581525
- Pharm Biol 60.1 (2022):1436-1448.PMID:35938494
- J Oncol 2022 (2022).PMID:35518787
- Front Pharmacol 16 (2025):1517221.
- Front Pharmacol 16 (2025):1562839.PMID:40183104
- Frontiers in Pharmacology 16 (2025):1547685.
- Neurotox Res 40.6 (2022):1895-1901.PMID:36223054
- J Biochem Mol Toxice 36.11 (2022):e23200.PMID:35997646
- J Cancer 11.5 (2020):1162.PMID:31956362
- Sci Rep-Uk 15.1 (2025):11639.PMID:40185911
- Cell Death Dis 16.1 (2025):287.PMID:40223081
- Int J Mol Med 49.3 (2022):1-11.PMID:35014672
- Arch Biochem Biophys (2025):110352.PMID:39978618
- Thorac Cancer 13.5 (2022):761-770.PMID:35098684
- Cell Signal (2025):111815.PMID:40258578
- Mol Immunol 152 (2022):27-34.PMID:36244215
- Front Genet 13 (2022):959109.PMID:36147489
- J. Cell. Mol. Med. 29.8 (2025):e70476.PMID:40275529
- Brain Res Bull 187 (2022):1-10.PMID:35738501
- Bioscience Rep 43.5 (2023):BSR20230028.PMID:37083601
- Biotechnol Genet Eng (2023):1-15PMID:37018431
- Environ Toxicol (2023).PMID:37052456
- Oncotargets Ther (2020):2511-2522.PMID:32280236
- Acta Diabetol 58.9 (2021):1251-1267.PMID:33907874
- J Endocrinol Invest (2025):1-16.PMID:39786708
- Biol 14.6 (2025):594.
- Neurochem Res (2023):PMID:37127800
- Toxicol Appl Pharm 422 (2021):115559.PMID:33961903
- Poultry Sci (2025):105339.
- Oncotargets Ther (2020):11301-11313.PMID:33177838
- Front Pharmacol 16 (2025):1565713.PMID:40474975
- Ann Transl Med 10.24 (2022).PMID:36660714
- Neuroscience (2023).PMID:37286157
- Sci Rep-Uk 10.1 (2020):20623.PMID:33244088
- J Inflamm Res (2025):7401-7417.PMID:40503490
- Oncol Rep 53.2 (2025):1-9.PMID:39670302
- Mol Cell Biochem (2023):1-11.PMID:36939994
- J Ethnopharmacol 259 (2020):112956.PMID:32442587
- J Ethnopharmacol 278 (2021):114275.PMID:34087404
- Oncol Rep 46.1 (2021):1-12.PMID:34080652
- Spectrochim Acta A 237 (2020):118387.PMID:32416513
- Brain Res Bull (2025):111245.PMID:39924054
- Biotechnol Genet Eng (2023):1-17.PMID:36946780
- Oncol Rep 53.2 (2025):1-9.PMID:39670302
- Bioorgan Med Chem 72 (2022):116994.PMID:36087428
- Bioorgan Med Chem 82 (2023):117234.PMID:36906964
- Front Genet 13 (2022):932973.PMID:36118847
- Sci Rep-Uk 15.1 (2025):794.
- Bioengineered 13.3 (2022):6650-6664.PMID:35230214
- MED ONCOL 42.4 (2025):1-13.PMID:40072654
- Bioengineered 13.3 (2022):6807-6818.PMID:35246020
- Oncol Res 32.6 (2024):1129.PMID:38827325
- Chem Biol Drug Des 99.6 (2022):828-838.PMID:35184389
- Cell Transplant 33 (2024).PMID:38334047
- Plos One 20.6 (2025):e0317930.PMID:40455747
- Virus Res 313 (2022):198748.PMID:35304133
- Carcinogenesis (2025):bgaf030.
- ONCOL LETT 29.6 (2025):1-12
- Mol Biotechnol 64.12 (2022):1367-1375.PMID:35639278
- Luminescence 39.1 (2024):e4671.PMID:38286599
- WORLD J GASTRO ONCOL 17.3 (2025):102187.PMID:40092949
- Technol Cancer Res T 19 (2020).PMID:33111613
- Bioengineered 13.5 (2022):11987-12002.PMID:35603556
- Comput Biol Chem (2025):108540.PMID:40483799
- Bioengineered 13.4 (2022):10335-10349.PMID:35435110
- Tissue Cell (2025): 102903.
- Cell Stress Chaperon 25 (2020):955-968.PMID:32572784
- Mol. Med. Rep. 31.5 (2025):1-12.PMID:40145553
- Curr Pharm Biotechno 23.8 (2022):1101-1108.PMID:34463226
- Kaohsiung J Med Sci (2025):e70031.PMID:40387410
- Mol Carcinogen (2025).PMID:40222040
- Bioengineered 12.1 (2021):6687-6702.PMID:34516362
- Microb Pathogenesis (2025):107720.PMID:40403987
- Bioengineered 12.1 (2021):8698-8708.PMID:34697986
- Tissue Cell (2024):102477.PMID:39018712
- METABOLITES 15.5 (2025):290.
- Biomarkers (2024):1-12.PMID:38568742
- Bioengineered 12.1 (2021):5985-5995.PMID:34477479
- Biochem Bioph Res Co (2025):151972.
- CURR ISSUES MOL BIOL 47.5 (2025):314.
- Acta Bioch Bioph Sin 56.5 (2024):776.PMID:38495003
- Chem Biol Drug Des 104.1 (2024):e14580.PMID:39031936
- Bmc Cancer 24.1 (2024):1-21.PMID:39085784
- J ORTHOP SURG RES 20.1 (2025):443.PMID:40319252
- Bba-Gen Subjects (2024):130628.PMID:38642815
- Discov Oncol 15.1 (2024):309.PMID:39060620
- J Appl Toxicol 42.5 (2022):830-840.PMID:34708435
- Bosn J Basic Med Sci 20.3 (2020):357.PMID:31733641
- Mol Cell Biochem 476 (2021):1387-1400.PMID:33389498
- Future Microbiol 0 (2024).PMID:38629914
- Chem Biol Drug Des 105.4 (2025):e70111.PMID:40247760
- J Integr Complement (2025).PMID:40459144
- Mol Biotechnol (2024):1-15.PMID:38771419
- J Mol Histol (2024):1-8.PMID:38758519
- Hum Mol Genet (2024):ddae122.PMID:39216871
- J Mol Neurosci 72.2 (2022):433-440.PMID:35023001
- Bioengineered 13.1 (2022):455-468.PMID:34967265
- Curr Stem Cell Res T 19.7 (2024):1021-1028.PMID:37861049
- Bioengineered 13.1 (2022):1518-1529.PMID:34986734
- J Mol Neurosci 74.1 (2024):30.PMID:38478195
- Bioengineered 12.2 (2021):11451-11460.PMID:34895055
- Toxicol Lett (2025).PMID:40412772
- Bioengineered 12.2 (2021):11936-11946.PMID:34784841
- Discov Oncol 15.1 (2024):280.PMID:39004679
- Gene 932 (2025):148898.PMID:39209182
- Mol Cell Biochem 473 (2020):179-192.PMID:32627113
- J Orthop Surg Res 18.1 (2023):910.PMID:38031136
- Mol Biol Rep 51.1 (2024):1-13.PMID:39422836
- Bmc Oral Health 24 (2024):1421.PMID:39574093
- Genomics (2025):111009.PMID:39864635
- Pharmacology 108.2 (2023):166-175.PMID:36724745
- N-S Arch Pharmacol (2024):1-21.PMID:39549064
- Pathogens 14.2 (2025):182.
- Mol Brain 18.1 (2025):1-23.PMID:39962509
- Dis Markers 2022 (2022).PMID:35845132
- Luminescence 40.2 (2025):e70095.PMID:39924164
- Luminescence 40.2 (2025):e70116.PMID:39914999
- Clin Exp Pharmacol P 50.11 (2023):903-913.PMID:37635387
- Thorac Cancer 14.9 (2023):815-826.PMID:36737402
- Mol Biol Rep 52.1 (2025):212.PMID:39921807
- Microb Pathogenesis (2024):107055.PMID:39442820
- Pathogens 14.2 (2025):182.
- Eur Rev Med Pharmaco 23.5 (2019).PMID:30915737
- Mol Med Rep 31.3 (2025):1-10.
- Eur J Med Res 30.1 (2025):54.PMID:39865289
- Shock 59.3 (2023):426-433.PMID:36609531
- Mol Med Rep 28.5 (2023):1-12.PMID:37732544
- Tissue Cell 80 (2023):102001.PMID:36565506
- J Orthop Surg Res 19.1 (2024):709.PMID:39487541
- Toxicol Appl Pharm (2025):117264.PMID:39952301
- Acta Bioch Bioph Sin 56.10 (2024):1473.PMID:38826133
- Acta Bioch Bioph Sin 56.10 (2024):1473.PMID:38826133
- J Tradit Chin Med 43.4 (2023):744.PMID:37454259
- J Orthop Surg Res 19.1 (2024):709.PMID:39487541
- Toxicol Appl Pharm (2025):117232.PMID:39832565
- Dis Markers 2022 (2022).PMID:35968506
- J Pharm Pharmacol 71.9 (2019):1412-1420.PMID:31282010
- Toxicon (2025):108293.PMID:39999927
- Front Med-Lausanne 11 (2025):1534120.PMID:39882536
- Clinics 77 (2022).PMID:35662010
- S Afr J Bot 177 (2025):445-456.
- Planta Med 89.05 (2023):493-507.PMID:35716667
- Heliyon (2024):.PMID:37461802
- Shock (2023):10-1097.PMID:37988072
- J Mech Behav Biomed (2025):106963.
- Int J Chronic Obstr (2023):919-932.PMID:37229441
- Plos One 19.12 (2024):e0316362.PMID:39724098
- Int J Chronic Obstr (2025):623-639.
- Shock (2023):10-1097.PMID:37179246
- CURR DRUG DELIV (2025).PMID:39976030
- J Sci Food Agr (2024).PMID:39394871
- FEBS Open Bio 12.1 (2022):146-153.PMID:34644456
- Dis Markers 2022 (2022).PMID:35845132
- N S Arch Pharmacol (2023):1-13.PMID:37160483
- Cell Mol Biol Lett 24.1 (2019):1-14.PMID:31889958
- J Int Med Res 48.4 (2020).PMID:31891283
- Clin Hemorheol Micro (2023):1-15.PMID:37212088
- Bmc Pediatr 25.1 (2025):42.PMID:39825267
- Adv Clin Exp Med 30.10 (2021):1031-1041.PMID:34329545
- Am J Transl Res 15.7 (2023):4873.PMID:37560235
- Anim Biotechnol (2023):1-12.PMID:36756956
- Open Life Sci. 20.1 (2025):20221056.
- Curr Cancer Drug Tar 24.9 (2024):975-986.PMID:38204265
- Exp Ther Med 20.4 (2020):3290-3300.PMID:32855700
- Vet Parasitol (2024):110284.PMID:39126893
- Immunobiology (2024):152832.PMID:38943814
- Pathol Res Pract 217 (2021):153284.PMID:33249400
- Chin J Integr Med (2024):1-11.PMID:38941045
- J Int Med Res 49.3 (2021).PMID:33730930
- Chin J Integr Med (2025):1-10.PMID:40338446
- Anticancer Res 43.8 (2023):3411-3418.PMID:37500147
- Cancer Biomark 42.5 (2025):18758592241306263.
- Am J Transl Res 14.10 (2022):6964.PMID:36398260
- Chem Biodivers 18.4 (2021):e2001007.PMID:33624427
- N S Arch Pharmacol (2023):1-13.PMID:37052642
- Pediatr Surg Int 39.1 (2022):54.PMID:36534156
- Biochem Genet (2023):1-18.PMID:37148331
- Balk Med J 41.6 (2024):491.PMID:39319820
- World J Oncol (2024):.
- Comb Chem High T Scr (2024).PMID:35894460
- Mol Cell Probe (2025):102031.
- Chem Biodivers 18.4 (2021):e2001007.PMID:33624427
- Oncol Res 33.1 (2024):103.PMID:39735676
- Hematology 28.1 (2023):2220522.PMID:37272581
- Genes Genom (2023):1-15.PMID:37318704
- Curr Mol Pharmacol 17.1 (2024).PMID:36946474
- Vet Microbiol (2025):110495.
- J Cardiothorac Surg 18.1 (2023):222.PMID:37420297
- Particul Sci Technol (2025):1-13.
- Balk Med J 41.6 (2024).PMID:39319820
- J Int Med Res 48.4 (2020).PMID:31891283
- Cell J 25.8 (2023):554.PMID:37641417
- Cell J 24.1 (2022):15.PMID:35182060
- Aesthet Plast Surg (2023):1-11.PMID:38148357
- J Obstet Gynaecol Re PMID:39169658
- Cell J 24.1 (2022):15.PMID:35182060
- Vet Parasitol 331 (2024):110284.PMID:39126893
- AESTHET PLAST SURG (2025):1-15.PMID:40180642
- Acta Histochem 125.8 (2023):152097.PMID:37813066
- Int J Gen Med (2022):3199-3213.PMID:35342302
- Ann Hepatol 27.4 (2022):100700.PMID:35338010
- Clin Cosmet Inv Dent (2022):87-94.PMID:35411190
- J Membrane Biol 253 (2020):43-55.PMID:31820013
- Endocr Metab Immune 24.1 (2024):153-162.PMID:37150983
- Cell Mol Biol 70.2 (2024):161-168.PMID:38430026
- Neuroreport 33.10 (2022):413.PMID:35623086
- J Toxicol Sci 48.8 (2023):469-479.PMID:37532580
- Bmc Nephrol 24.1 (2023):314.PMID:37884904
- TRANSL ANDROL UROL 14.2 (2025):36078-36378.PMID:40114844
- J Asian Nat Prod Res 24.11 (2022):1078-1085.PMID:34935551
- Discov Oncol 14.1 (2023):1-10.PMID:37907650
- Pediatr Surg Int 40.1 (2024):63.PMID:38431920
- Int J Gen Med (2022):3199-3213.PMID:35342302
- Fitoterapia (2024):106245.PMID:39393711
- Cell Mol Biol 69.12 (2023):223-231.PMID:38063090
- J Obstet Gynaecol Re PMID:39169658
- Clin Cosmet Inv Dent (2022):87-94.PMID:35411190
- PeerJ 13 (2025):e19083.
- Crit Rev Eukar Gene (2025).
- Transpl P 52.1 (2020):398-405.PMID:31928781
- J Craniofac Surg 33.4 (2022):1250-1254.PMID:36041089
- Iran J Immunol (2023).PMID:37865874
- J Herbs Spices Med P (2025):1-16.
- Transl Cancer Res 13.4 (2024).PMID:38737693
- J Cardiothorac Surg 20.1 (2025):53.PMID:39794868
- Drug Dev Res 81.4 (2020):437-443.PMID:31904108
- Bioact Mater 44 (2025):220-235.
- Heliyon (2024).
- Biomed Pharmacother 179 (2024):117370.
- Phytomedicine (2024):156091.
- Int J Bioprinting (2024).
- Pharmaceuticals-Base 17.10 (2024):1295.
- J Hazard Mater (2024):136113.
- J King Saud Univ Sci 32.7 (2020):2912-2919.
- Front Oncol 10 (2020):387.
- Chem Eng J (2024):156542.
- Mater Express 10.1 (2020):102-111.
- Netw Model Anal Hlth 13.1 (2024):1-15.
- J Funct Foods 123 (2024):106621.
- Int J Mol Sci 25.19 (2024):10496.
- Drug Des Dev Ther (2024):5841-5851.
- Int J Mol Sci 25.19 (2024):10339.
- scienceasia (2024).
- Cell Biomaterials (2025):
- Am J Cancer Res (2024):2852-2867.
- Bioact Mater 36 (2024):524-540.
- J Transl Med 22.1 (2024):1-16.
- Green Process Synth 13.1 (2024):20240050.
- hLife (2024).
- Carbohyd Polym (2024):122897.
- Front Pharmacol 15:1453938.
- Bioorg Chem (2024):107731.
- Acs Appl Mater Inter (2024).PMID:39167710
- J Hazard Mater (2024) 135735.
- Antioxidants 13.11 (2024) 1320.
- Antioxidants-Basel 13.11 (2024):1289.
- bioRxiv (2024) 2024-10.
- Front Bioeng Biotech 12 (2024):1460870.
- Adv Funct Mater 29.50 (2019):1906690.
- Biomedicines 12.11 (2024):2543.
- Ecotox Environ Safe 286 (2024):117233.
- Front Pharmacol 15 (2024):1384141@0.jpg
- Acs Appl Nano Mater (2024).
- New J Chem 48.11 (2024):5068-5073.
- Mol Ther Nucl Acids (2020).
- bioRxiv (2025):2025-01.
- Gene (2024) 149056.
- J Transl Med 22.1 (2024) 1-16.
- Phytother Res 34.4 (2020):836-845.
- ACS Appl. Eng. Mater. (2025).
- Small (2024):2402308.PMID:3911
- Viruses 16.8 (2024):1239.
- Faseb J 38.15 (2024):e23876.
- J Nutr Biochem (2024):109769.PMID:9276944
- Rev Bras Farmacogn (2024):1-7.
- Biosens Bioelectron (2024):116875.
- Toxins 16.7 (2024):319.
- J Pharm Anal (2024):101053.
- Nutrients 16.14 (2024):2314.
- Drug Resist Update (2024):101161.
- Nutrients 16.14 (2024):2346.
- Acs Omega (2024).
- Int J Biol Sci 20.12 (2024):4713-4730.
- J Integr Med-Jim (2024).
- Int J Mol Sci 25.20 (2024):11184.
- Bioact Mater 43 (2025):32-47.
- Heliyon (2024).
- Heliyon (2024).
- Indian J Pharm Sci 86.3 (2024).
- J Tradit Compl Med (2024).
- Int J Mol Sci 25.15 (2024):8340.
- Mater Res Express 7.2 (2020):025401.
- Front Mar Sci 9 (2022):861117.
- J Clean Prod 315 (2021):128201.
- Acta Pharmacol Sin 44.1 (2023):255-257.PMID:35773339
- Pharmaceuticals-Base 16.10 (2023):1482.PMID:37895953
- Dis Markers 2022 (2022).
- Vaccines-Basel 11.11 (2023):1678.PMID:38006011
- Front Immunol 14 (2023).PMID:37901236
- Discov Oncol 13.1 (2022):71.PMID:35941331
- Int J Mol Sci 23.16 (2022):9014.PMID:36012290
- Int J Mol Sci 24.19 (2023):15003.PMID:37834451
- Viruses 14.8 (2022):1783.PMID:36016405
- Biochip J (2023):1-10.
- J Oncol 2022 (2022).PMID:36059813
- Mol Cell Toxicol (2023):1-10.
- Oxid Med Cell Longev 2022 (2022).PMID:35936222
- Molecules 27.16 (2022):5337.PMID:36014573
- Cancers 14.19 (2022):4645.PMID:36230568
- Trop J Pharm Res 22.9 (2023):1857-1862.
- Trop J Pharm Res 22.9 (2023):1779-1784.
- Sensor Actuat B Chem 394 (2023):134396.
- Phytother Res 37.2 (2023):477-489.PMID:36199227
- Int J Mol Sci 24.21 (2023):15545.PMID:37958531
- Pharmaceutics 14.10 (2022):2157.PMID:36297592
- Mol Cell Oncol 10.1 (2023):2238873.PMID:37649964
- Crit Rev Eukar Gene 34 (2024).
- J Oncol 2022 (2022).PMID:35909906
- Microorganisms 11.9 (2023):2258.PMID:37764102
- Int J Gen Med (2023):5817-5839.PMID:38106976
- Front Pharmacol 13 (2022):899775.PMID:35571096
- Front Cell Infect Mi 12 (2022):423.PMID:35573770
- Clin Transl Disc 2.2 (2022):e49.
- Acta Trop 232 (2022):106519.PMID:35584779
- Cytotechnology 74.3 (2022):421-432.PMID:35733701
- Phytomedicine 103 (2022):154199.PMID:35679793
- Adv Funct Mater (2023):2309690.
- Oncol Rep 51.2 (2024):1-13.PMID:38131250
- Biomed Pharmacother 170 (2024):116042.PMID:38118351
- Foods 11.11 (2022):1575.PMID:35681325
- Ann Hematol (2023):1-12.
- Int J Biol Sci 20.2 (2024):433-445.PMID:37379961
- Pharmaceutics (2023) 15(12):2713.
- Oxid Med Cell Longev 2022 (2022).PMID:35770048
- Mater Today Adv 15 (2022):100271.
- Transl Cancer Res 11.6 (2022):1781.PMID:35836521
- Food Sci Nutr (2023).
- Carbohyd Polym 295 (2022):119878.PMID:35989018
- Biocell 47.8 (2023).
- Phytomedicine 105 (2022):154330.PMID:35905566
- Biomaterials Advances 142 (2022):213165.PMID:36341744
- Cancers 14.21 (2022):5218.PMID:36358640
- Int J Mol Sci 23.8 (2022):4128.PMID:35456945
- Front Microbiol 14 (2023).PMID:37645224
- Appl Entomol Zool 58.4 (2023):303-313.
- Aging (Albany NY) 15.12 (2023):5713PMID:37390121
- Int J Mol Sci 24.7 (2023):6279.PMID:37047251
- J Inflamm Res (2023):1045-1057.PMID:36936349
- View-China 4.2 (2023):20220052.
- ACS omega 8.30 (2023):27146-27155.PMID:37546678
- Plos Pathog 19.4 (2023):e1011305.PMID:37053288
- bioRxiv (2023):2023-05.PMID:37292976
- Iscience 26.9 (2023).PMID:37670789
- Curr Issues Mol Biol 45.5 (2023):4017-4034.PMID:37232725
- Oxid Med Cell Longev 2023 (2023).PMID:36778205
- J Thorac Dis 15.4 (2023):2198.PMID:37197522
- Ceram Int 49.15 (2023):25953-25963.
- Colloid Surface B 228 (2023):113364.PMID:37290201
- Oncol Lett 26.1 (2023):1-17.
- Adv Funct Mater (2023):2214998.
- Nanophotonics 11.22 (2022):5089-5100.
- Cancer Res Commun 2.6 (2022):471-482.PMID:36338546
- Acs Appl Polym Mater 4.10 (2022):7014-7024.
- bioRxiv (2022):2022-04.
- Int J Pept Res Ther 29.2 (2023):19.
- Crystals 13.7 (2023):1067.
- J Agr Food Chem 70.44 (2022):14220-14234.PMID:36300841
- Mater Today Chem 27 (2023):101331.
- Cells 11.22 (2022):3580.PMID:36429010
- J-Ethnopharmacol 318 (2024):116961.PMID:37541404
- Int J Nanomed (2023):5423-5440.PMID:37767196
- Mol Cell Toxicol (2022):1-11.
- Histol Histopathol 35.9 (2020):919-927.PMID:32282924
- Exp Ther Med 26.5 (2023):1-15.PMID:37869642
- Chem Eng J 474 (2023):145358.
- Cell Mol Biol 69.5 (2023):44-50.PMID:37571902
- Acs Appl Bio Mater 6.1 (2023):74-82.PMID:36603189
- Int J Mol Sci 24.2 (2023):1243.PMID:36674761
- Mol Med 29.1 (2023):6.PMID:36647009
- Exp Ther Med 25.2 (2023):1-10.PMID:PMID_36684652
- Biocell 47.8 (2023).
- Vaccines Basel 11.7 (2023):1190.PMID:37515006
- Aquaculture 564 (2023):739060.
- Drug Develop Res 84.2 (2023):312-325.PMID:36658741
- Poultry Sci 102.10 (2023):102946.PMID:37542939
- Sensor Actuat B-Chem 381 (2023):133437.
- J-Ethnopharmacol 318 (2024):116969.PMID:37516391
- Poultry Sci 102.4 (2023):102511.PMID:36805396
- Int Immunopharmacol 123 (2023):110709.PMID:37515849
- Adv Funct Mater (2024):2305827.
- Phytomedicine (2024):155347.
- Chin Herb Med (2024).
- J Inflamm Res 14 (2021):2445.
- bioRxiv (2024):2024-05.
- Adv Funct Mater (2024):2400489
- Transl Cancer Res 13.4 (2024).
- Phytomedicine (2024):155656.
- Mol Biotechnol 63.8 (2021):686-693.PMID:33977498
- Compos Part B-Eng 220 (2021):108984.PMID:35988999
- Diabet Metab Synd Ob (2021):2255-2268.PMID:34045875
- Acs Appl Bio Mater 4.6 (2021):5026-5032.
- Exp Eye Res 209 (2021):108642.PMID:34058232
- HemaSphere 5.7 (2021).PMID:34136753
- Open Med-Warsaw 16.1 (2021):558-569.PMID:33869778
- Cancer Manag Res (2021):4709-4723.PMID:34163246
- Pharmaceuticals-Base 17.4 (2024):515.
- Cells 13.9 (2024):728.
- Food Hydrocolloid 120 (2021):106980.
- Oxid Med Cell Longev 2021 (2021):1-30.PMID:34257808
- Applied Sciences 14.8 (2024):3186.
- Adv Funct Mater (2024):2402663.
- Appl Entomol Zool (2022):1-14.
- Acs Pharmacol Transl (2024).
- Phytomedicine 86 (2021):153565.PMID:33945919
- Phytomedicine (2024):155744.
- J Inflamm Res 14 (2021):3523.PMID:34335041
- Pharmaceutics 16.6 (2024):744.
- Acs Omega (2024).
- Talanta (2024):126381.
- Mol Ther-Nucl Acids (2020).
- Mol Cell Biochem (2024) 1-13.
- J Cancer 15.13 (2024):4244-4258.
- J Pharm Sci 75.10 (2020):505-509.PMID:33305726
- Nat Commun 15.1 (2024):4969.PMID:38862489
- Int J Mol Sci 21.21 (2020):8095.PMID:33142980
- Heliyon (2024).
- Anal Cell Pathol 2020 (2020).PMID:33354489
- Front Cell Neurosci 15 (2021):569424.PMID:33815059
- Phytomedicine (2024):155767.
- Molecular Therapy Oncology (2024).
- Front Pharmacol 11 (2021):618262.PMID:33551818
- J Biol Chem 297.2 (2021).PMID:33722608
- Theranostics 14.7 (2024):2687.
- Front Cell Dev Biol 8 (2021):568304.PMID:33763412
- Front Pharmacol 15 (2024):1389976.
- Available at SSRN 4830418.
- Biomaterials 272 (2021):120757.PMID:33798960
- Heliyon (2024).
- Fiber Polym (2022):1-9.
- Sensors & Diagnostics (2024).
- J Biomed Nanotechnol 20.1 (2024):133-142.
- Front Immunol 15 (2024):1326137.
- Transl Cancer Res 11.1 (2022):206.PMID:35261897
- Tissue Cell 76 (2022).PMID:35182988
- Antioxidants Basel 13.3 (2024):264.
- New J Chem (2024).
- Pharmacol Res 177 (2022):106112.PMID:35122955
- Kaohsiung J Med Sci (2024).PMID:38340032
- J Ethnopharmacol (2024):117867.PMID: 38342155
- Nano Today 43 (2022):101416.
- Front Immunol 15 (2024):1347683.PMID:38343537
- J Funct Foods 114 (2024):106076.
- Bba-Mol Cell Biol L 1867.6 (2022):159137.PMID:35247568
- Front Oncol 12 (2022):851300.PMID:35392243
- Oncol Lett 23.5 (2022):1-8.PMID:35350588
- J Cancer 13.6 (2022):1808.PMID:35399733
- bioRxiv (2024):2024-02.
- Mater Today Bio (2024):100958.
- Cell Death Dis 15.1 (2024):97.PMID:38286802
- Bioengineered 13.4 (2022):9145-9155.PMID:35363601
- Int J Mol Sci 25.2 (2024):919.
- Phytochem Lett 47 (2022):174-179.
- Bio-Des Manuf 5.2 (2022):358-370.
- Acs Appl Opt Mater (2024).
- Nano Res (2022):1-8.
- Redox Biol (2024):103143.
- Biomed Res Int 2021 (2021).PMID:34373837
- Nanoscale (2024).
- J Agr Food Chem (2024).
- Dis Markers 2021 (2021):1-12.PMID:34413913
- Nanomaterials 11.8 (2021):2008.PMID:34443839
- Int J Mol Sci 22.16 (2021):8898.PMID:34445601
- Cells 10.9 (2021):2399.PMID:34572049
- New J Chem 48.11 (2024):5068-5073.PMID:PMID
- Phytochem Lett 46 (2021):79-89.
- Mater Design (2024):112812.
- Exp Ther Med 27.5 (2024):1-16.
- J Environ Pathol Tox 42 (2023).PMID:36749091
- Carbohyd Polym 277 (2022):118869.PMID:34893274
- Fitoterapia (2024):105884.
- Eur J Med Chem (2024):116323.PMID:(2024) 116323.
- PeerJ 9 (2021):e11482.PMID:34820154
- Tissue Cell 74 (2022):101680.PMID:34808429
- Nano Today 41 (2021):101326.
- Exp Ther Med 23.2 (2022):1-9.PMID:35069838
- Exp Ther Med 23.2 (2022):1-9.PMID:35069839
- Int J Mol Sci 25.24 (2024):13439.
细胞计数试剂盒-8(CCK-8)使用WST-8(2-(2-甲氧基-4-硝基苯基)-3-(4-硝基苯基)-5-(2,4-二磺酚基)-2H-tetrazolium,单钠盐),在存在电子载体1-Methoxy PMS的情况下,产生水溶性福尔马定染料进行方便的测定。 CCK-8溶液直接加入到细胞中,无需预先混合组分。 WST-8被细胞脱氢酶生物还原为可溶于组织培养液的橙色福尔马定产物。 产生的福尔马定量与活着的细胞数量成正比。由于CCK-8溶液非常稳定且具有很小的细胞毒性,因此可以进行更长时间(例如24至48小时)的孵育。
细胞计数试剂盒 - 8允许灵敏度高、用于增殖和毒性测定中确定存活细胞数量的显色法检测。 检测灵敏度比MTT、XTT或MTS等任何其他四唑盐都要高。
图1:Cell Counting Kit-8(CCK-8)的工作机制。
细胞数量确定
1.将细胞悬浮液(100μL/孔)接种在96洞孔板中。将板在潮湿的培养箱中预孵育(例如,在37℃,5%CO2下)。
2.向板的每个孔中加入10μLCCK8溶液。注意不要在孔洞中引入气泡,因为它们会干扰O.D.读数。
3.将培养板在培养箱中孵育1-4小时。
4.使用酶标仪测量450 nm处的吸光度。
细胞增殖和细胞毒性测定
1.将种子细胞以103-104个细胞/孔的密度在96孔板中在100μL培养基中培养。将细胞在CO2培养箱中于37℃培养24小时。
2.将不同浓度的待测物质加入板中。
3.将培养板在培养箱中孵育适当的时间(例如,6,12,24或48小时)。
4.使用重复移液器向板的每个孔中加入10μLCCK8溶液。注意不要在孔洞中引入气泡,因为它们会干扰O.D.读数。
5.将培养板在培养箱中孵育1-4小时。
6.在读取孔板之前,重要的是在轨道振动器上轻轻混合1分钟,以确保颜色均匀分布。
7.使用酶标仪测量450 nm处的吸光度。
数据分析
统计分析有几种方法,您可以选择使用O.D.值或细胞数量,我们提供其中一种方法。
细胞存活率(%)= [(As-Ab)/(Ac-Ab)]×100
抑制率(%)= [(Ac-As)/(Ac-Ab)]×100
As =实验孔吸光度(含有细胞,培养基,CCK-8和待测化合物的孔的吸光度)。
Ab =空白孔吸光度(含有培养基和CCK-8的孔的吸光度)。
Ac =对照孔吸光度(含有细胞,培养基和CCK-8的孔的吸光度)。
制作标准曲线
1. 细胞计数板计数细胞悬液中的细胞数。
2. 使用培养基,等比稀释细胞悬液为一个浓度梯度,通常需要5-7个浓度梯度,每组几个复孔。然后接种细胞。(注意每孔的细胞数量。如果您将细胞悬液稀释在管中,在加入培养板的孔之前,请小心再次混匀细胞。每孔中细胞悬液的体积应该是一致的。)
3. 培养直至细胞贴壁(通常2-4小时),然后每100 μl培养基加入10 μl CCK-8。继续孵育1-4小时,用酶标仪测量450nm处的吸光度。制作出一条以细胞数为X轴坐标,O.D.值为Y轴坐标的标准曲线。
可以基于该曲线确定待测样品的细胞数。使用此标准曲线的先决条件是培养检测条件相同。
注意事项
1. 确保药物和CCK8均匀分布在培养基中。
2. 细胞增殖越多, 颜色越深; 细胞毒性越强,颜色越浅。
3. 对于贴壁细胞,每孔至少需要1000个细胞(100 μl培养基)。对于白细胞,由于灵敏度较低,每孔至少需要2500个细胞(100 μl培养基)。推荐的96孔板每孔最大细胞数为25000。如果使用24孔或6孔板进行该检测,请计算相应的每孔的细胞数,并调整CCK-8的体积,使其为每孔总液体体积的10%。
4. 因为CCK8测定是基于活细胞中的脱氢酶活性,影响脱氢酶活性的条件或化学物质可能导致实际活细胞数与使用CCK-8测定活细胞数之间有差异。
5. WST-8可能与还原剂反应生成WST-8 formazan。如果使用还原剂 (例如一些抗氧化剂)会干扰检测。如果待检测体系中存在较多的还原剂,需设法去除。
6. 孵育2小时后,背景O.D.值一般为0.1-0.2单位。
7. 注意不要在孔中引入气泡,因为它们会干扰O.D.值。
8. 如果您想对CCK8溶液进行灭菌,请使用0.2 μm的膜过滤溶液。
9. 孵育时间因孔中细胞的类型和数量而异。通常,白细胞着色较弱,因此可能需要较长的孵育时间(长达4小时)或大量细胞(~105细胞/孔)。
10. 如果细胞悬液中存在高浊度, 测量并减去样品在600nm或更高波长的O.D值。
11. CCK8不能用于细胞染色。
12. 培养基中的酚红不会影响实验结果,酚红的吸光度可以在计算时,通过扣除空白孔中本底的吸光度而消去,因此不会对检测造成影响。
13. CCK8的毒性非常低,在CCK8测定完成后,相同的细胞可用于其他细胞增殖测定,例如结晶紫测定,中性红测定或DNA荧光测定。(除非细胞极为稀少,不推荐。)
14. 该试剂盒可用于大肠杆菌,但不能用于酵母细胞。
15. 在读取平板之前,您可以在摇床上轻柔混匀。
16. 我们建议将细胞接种在靠近培养板中央的孔中,最外围一圈孔中的培养基容易蒸发,可以用PBS,水或培养基填充这些孔。
17. 如果您没有450nm滤光片。您也可以使用吸光度在430和490nm之间的滤光片, 450nm滤光片具有最佳灵敏度。
18. 测量450nm处的吸光度,如果您需要进行双波长测定,作为参考波长可以测定650nm处的吸光度。
19. 药物中金属离子的存在可能会影响CCK8的灵敏度。终浓度为1mM的氯化亚铅、氯化铁、硫酸铜会抑制 5%、15%、 90% 的显色反应,使灵敏度降低。如果终浓度是10mM的话,将会100%抑制。
常见问题
Q:如何做空白对照?
A:可以用加相应量细胞培养基和CCK-8但不加细胞的孔作为空白对照,若担心所使用的药物会干扰检测,需设置加相应量细胞培养液、药物和CCK-8但不加细胞的孔作为空白对照。
Q:只加CCK-8不加细胞的空白孔,数值上增?
A:在整个实验过程中,随着时间的增加,如果细胞培养时间较长,请注意蒸发问题。因为反应环境温度较高,会有部分液体挥发。空白组虽然没有细胞,但是随着液体的挥发,药物浓度相当于提高了,所以空白对照的数值也会有轻微的变化(但不会有明显的变化)。如果很在意空白对照的数值,可将96孔板外围一圈加培养基、水或PBS 保湿。同时,可以把96孔板置于培养箱内靠近水盘的位置以缓解蒸发。将96孔板外围两圈用PBS铺板,这样挥发先挥发周边的,可以对内部及空白对照的影响降至最低。
Q:一般多久测一次值?
A:预实验时可以在0.5、1、2和4小时后分别用酶标仪检测,然后选取吸光度范围比较适宜的一个时间点用于后续实验。
Q:加入CCK8后暂时不测OD值,可以如何处理暂时保存?能够保存多久?
A:如果需要暂时不测定OD值,可以向每孔中加入10ul 0.1M HCl溶液或者1% w/v的SDS溶液,避光保存在室温,24小时内吸光度不会发生变化。
Q:如何保存?
A:CCK-8溶液在避光、0-5℃的条件下可以保存1 年,若长期不用可在-20℃下避光保存2年。建议分装后保存于-20℃,使用时提前于4℃解冻,请避免反复冻融,否则增加背景值,干扰实验结果。
Q:是否需要更换培养基?
A:不需要,若药物影响比较小的情况可以不更换培养基,直接扣除培养基中加入药物后的空白吸收即可。
Q:待测物质有氧化性或还原性该做何处理?
A:本试剂盒的检测依赖于脱氢酶催化的反应,如果待测物质有氧化性或还原性,可在加CCK-8之前更换新鲜培养基,去掉药物的影响。
如果实验中有还原剂,请检查背景的OD值,即在不含细胞的培养基中加入药物,然后加入CCK-8试剂在一定时间内检测,和不加药物的培养基进行比较(只有CCK-8试剂),如果O.D值明显偏高,则说明有反应。
Q:如果培养基颜色或PH已变化,是否需要更换新的培养基?
A:加入CCK-8时,如果细胞培养时间较长,培养基颜色或pH值已变化,建议换用新鲜的培养基。
Q:适用细胞?
A:因为测线粒体酶,所以真核细胞,有线粒体的均可,例如单细胞,动物细胞。但有细胞壁的细胞,例如植物细胞,酵母细胞,底物进入细胞效率低,不推荐。
Q:线性不佳原因?
A:细胞不均;培养液蒸发;还原剂;气泡;孔板周围一圈不能用,除非只培养少于一天的时间;细胞数目很重要,太少信号会低。
Q:金属毒性?
A:可以检测金属毒性,最好做空白对照。
Q:适用于那些细胞?其他还有哪些细胞可用?生物被膜内的活菌 (流感嗜血杆菌和绿脓杆菌)?
A:所有哺乳动物的细胞,细菌一般没有检测CCK8的,可以染色法,或者流式,最常规的方法,有报道, 比浊法测OD600。
Q:是否可以替代Brud或EDU法检测细胞增殖?
A:虽然CCK8通过检测对生长期的细胞内的脱氢酶来反应细胞的活性,而胸腺嘧啶插入法通过核苷酸类似物的方式插入合成的DNA来检测细胞的活性,这几种方法是有一定关联性的,CCK8可替换胸腺嘧啶插入法来检测细胞增殖,并且检测更方便。
Q:空白孔数值偏高,有可能是培养基长菌吗?或者其他原因?
A:空白孔数值偏高一般认为染菌造成的,很少出现这种问题。
Q:CCK8能检测组织吗
A:不能检测组织。
Q:是否可以检测T细胞
A:可以,T细胞长的慢,需延长孵育时间。
Q:当两个细胞混合培养时(骨髓间充质细胞,另一个是悬浮T细胞),培养一段时间后,只测骨髓间充质干细胞的生长、增殖情况,请问用CCK-8能测吗?怎么做?
A:对于两种细胞的情况:
1)如果测定贴壁细胞的生长状况,那么可以把悬浮的T细胞转移掉,使用上述第二种方法测定。
2)如果T细胞对于间充质细胞的生长很关键,不能取走,那么测定的活性程度是总量,此时,需要对每一个孔的T细胞进行估算,如果每个培养条件下T细胞总量接近,或者T细胞含量很少,远远小于间充质细胞,也可以测定,使用对照孔可以去除T细胞的影响。
3)如果T细胞可以短时间内除去,可以找个灵敏度高的CCK-8,信号强,建议细胞量合适的情况下(每一个孔10000个),30分钟左右出读数结果,测 定后,可以将T细胞再加入培养孔。 这样做对细胞的生长影响不大。但是如果做动力学,那么要考虑的因素多一些。
Q:CCK-8是通过和细胞内的脱氢酶反应而反映着细胞数量,假如细胞已经死亡,而脱氢酶活性还有,那么如何计算细胞数量?
A:多数情况下,细胞死亡过程中,细胞内的成分会降解,脱氢酶会有部分释放,但是活性和活细胞比,比较低。举例说:100个细胞死亡20小时后,释放的脱氢酶活力,不足5个活细胞的脱氢酶活力,也就是说,这种情况带来的误差5%以内。而且,这种细胞死亡,对同种细胞来说,情况是一样的,一般都是在不同的孔间比较同种细胞,所以系统误差是一样的,即系统误差会彼此消减。
应用&特点 |
1) 细胞增殖测定 - GlpBio细胞计数试剂盒-8(CCK-8)是水溶性的,在培养中是稳定的,并且是无毒的。 2) 细胞活力测定 - 代谢活性和染料产生与改变的活力成比例地变化。 3) 细胞因子测定 - 测量细胞因子诱导的增殖。如果需要,可以在研究结束时回收细胞并扩增。 4) 细胞毒性测定 - 来自细胞毒性化学物质的细胞死亡对颜色发展没有影响,只有活细胞将试剂转化为比色指示剂。试剂本身具有可忽略的毒性,并且通常对细胞是安全的。 |
运输方式 | 蓝冰运输。 |
储存条件 | 储存在4°C避光,可稳定长达12个月。储存在-20°C避光,可稳定长达2年。 |
用途 | 仅供研究使用!不能用于人体。 |
CCK-8 | MTT | MTS | SRB |
Solubility | Water soluble | Indissolvable | Water soluble | Indissolvable |
Detection Wavelength | 450nm | 490nm | 450nm | 510nm |
Character | Liquid | Solid | Liquid | Liquid |
Usage | No need to prepare | Prepare the solutions | Use it right after it was ready | Prepared beforehand |
Need to redissolve or not | NO | Yes,by DMSO | No | Yes,by Tris-base solution |
Convenience | +++ | ++ | +++ | + |
Detection speed | +++ | + | ++ | + |
Repeatability | +++ | + | ++ | ++ |
Stability | ++ | + | + | +++ |
-
Related Biological Data
Therapeutic targeting of the DDR1–NF-κB–NRF2 axis inhibits PDAC growth and metabolism. a, Parental and E79Q KPC cells plated on wild-type or R/R ECM were incubated in LG medium with or without 7rh, ML120B or ML385. Total viable cells are presented relative to parental cells that were treated with vehicle and plated on wild-type ECM.
Cell viability was determined with a Cell Counting Kit-8 assay (Glpbio).
Nature 610.7931 (2022): 366-372. PMID: 36198801 IF: 69.5026 -
Related Biological Data
LIG1 reversed cell proliferation, apoptosis and DNA damage effects of hsa_circ_0007919 (A-B) CCK-8 analysis of the proliferation of GEM-resistant PDAC cells with or without LIG1 inhibition.
EIPA , IPI549, MBQ-167, MRT68921 or erlotinib, ML385, HCQ or their combinations were added to the wells for 24, 72 or 96 hrs. Next, 10 uL of CCK-8 (GlpBio) was added to each well.
Cancer Cell (2021). PMID: 33740421 IF: 38.5836 -
Related Biological Data
Effect of CrEL on glucose transport.Cell Counting Kit-8 (CCK-8) is a fluorescent glu-cose analog. INK-128 (mTORi) was used as a control for de-creased glucose transport.
Cells after transfection or GEM treatment were collected and counted, then 4 × 103 cells were placed into 96-well plate and cultured in incubator at 37°C. 24, 48, 72 and 96 h after, cells were incubated with 100 μl serum-free medium and 10 μl CCK-8 solution (Glpbio, USA) at 37°C for 2 h and measured at 450 nm wavelength.
Molecular Cancer, 2023, 22(1): 195. PMID: 38044421 IF: 37.2999 -
Related Biological Data
Bifidobacterium cultural supernatant and I3C protected mice against ALF. (G-H) Primary hepatocytes were pre-treated with or without I3C for 1 h followed by PBS or APAP administration for 12 h. The effects of I3C on CCK8 (G) and LDH (H) were detected. n=3-5.
Cell counting kit 8 (CCK8) experiment for in vitro assay were performed using the CCK8 Kit (Glpbio, Cat# GK10001, USA) according to the manufacturer's instructions.
Cell Host & Microbe 32.1 (2024): 48-62. PMID: 38056458 IF: 30.3013 -
Related Biological Data
Fe3O4@IR820@CpG induces immunogenic cell death and promotes DC maturation in vitro. A,B) Viability of MC38 cells after incubation with A) different concentrations of Fe3O4@IR820@CpG without laser irradiation or B) different formulations with 808 nm laser irradiation (1 W cm−2) for 5 min, as detected by CCK-8 kit (n = 4).
Bicinchoninic Acid Assay (BCA) protein assay kit,cell counting kit-8 (CCK-8), and erythrocyte membrane lysates were purchased from GlpBio (Montclair, USA).
Advanced Materials, 2023: 2307193. PMID: 37951210 IF: 29.4006 -
Related Biological Data
H) The viability ofMC38 cells treated with PAD@MS for 48 h in the presence or absence of 10 μM Ferr-1, 20 μM Nec-1, 10 μM z-VAD-FMK, and 1 mM NAC.
Cell viability was detected by cell counting kit-8 (CCK-8) assay (GlpBio, USA) according to the manufacturer’s instruction.
Adv Funct Mater, 2023: 2214998. IF: 19.9246 -
Related Biological Data
After transfection with si-1 and si-2, performed CCK-8 assays were performed to evaluate the cellular growth curves and the results revealed that repressing the expression of PCAT6 remarkably suppressed the cell proliferation of HeLa and SiHa cells.
Each well was added with 10 μl CCK-8 reagent (GLPBIO, Montclair, CA, USA) and the plates were continued to be cultured for 1-2 h. The cell viability was determined by measuring the optical density (OD) absorbance at the wavelength of 450 nm.
Eur Rev Med Pharmacol Sci.2019 Mar;23(5):1947-1956 -
Related Biological Data
Blocking bFGF leads to decrease in cell proliferation and clone formation of cisplatin (DDP) selected A549 cells. Growth curves showed that knocking down bFGF expression resulted in reduction in cell proliferation.
The cells were incubated for 24 h in incubator, and then,10μl CCK-8 (GLPBIO) was added in every well and cultivated at room temperature for 4 h. Absorbance was measured at 450 nm. The experiment repeated three times successive 7 days.
J Pharm Pharmacol.2019 Sep;71(9):1412-1420.